Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person Orlic-Milacic, Marija, 2022-11-09
| Class:Id | InstanceEdit:9820558 |
| _displayName | Orlic-Milacic, Marija, 2022-11-09 |
| _timestamp | 2022-11-09 16:55:10 |
| author | [Person:1169272] Orlic-Milacic, Marija |
| dateTime | 2022-11-09 16:55:08 |
| (modified) | [PathwayDiagram:1227987] Diagram of Signaling by ERBB2, Constitutive Signaling by Overexpressed ERBB2, Signaling by ERBB2 KD Mutants, Resistance of ERBB2 KD mutants to trastuzumab, Resistance of ERBB2 KD mutants to lapatinib, Resistance of ERBB2 KD mutants to neratinib, Resistance of ERBB2 KD mutants to osimertinib, Resistance of ERBB2 KD mutants to afatinib, Resistance of ERBB2 KD mutants to tesevatinib, Resistance of ERBB2 KD mutants to sapitinib, Resistance of ERBB2 KD mutants to AEE788, Signaling by ERBB2 ECD mutants, Signaling by ERBB2 TMD/JMD mutants, and Drug resistance in ERBB2 TMD/JMD mutants [Reaction:9665696] ERBB2 TMD/JMD mutants bind trastuzumab [Homo sapiens] [Reaction:9665702] ERBB2 TMD/JMD mutants bind TKIs [Homo sapiens] [Reaction:9665703] ERBB2 TMD/JMD mutants bind pertuzumab [Homo sapiens] [Complex:9665939] ERBB2 TMD/JMD mutants (TKI sensitive):ERBIN:HSP90:CDC37 [plasma membrane] [Homo sapiens] [Complex:9665958] ERBB2 TMD/JMD mutants (trastuzumab):ERBIN:HSP90:CDC37 [plasma membrane] [Homo sapiens] [Complex:9665968] ERBB2 R678Q:ERBIN:HSP90:CDC37 [plasma membrane] [Homo sapiens] |
|
[Change default viewing format]
|
No pathways have been reviewed or authored by Orlic-Milacic, Marija, 2022-11-09 (9820558)